L3VLUP
ProSign in

PRGO · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

PRGOJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • PRGO
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterPRGOJNJ
Q3 202010 holders, $958m30 holders, $26.2bn
Q4 20208 holders, $897m32 holders, $26.6bn
Q1 20217 holders, $1.1bn31 holders, $25.3bn
Q2 20219 holders, $1.3bn37 holders, $25.6bn
Q3 20219 holders, $1.1bn40 holders, $24.1bn
Q4 20219 holders, $534m33 holders, $25.2bn
Q1 202210 holders, $637m35 holders, $28.2bn
Q2 202212 holders, $565m33 holders, $26.9bn
Q3 20229 holders, $258m36 holders, $25.4bn
Q4 20229 holders, $168m35 holders, $27.6bn
Q1 20239 holders, $183m42 holders, $24.5bn
Q2 20237 holders, $123m38 holders, $25.0bn
Q3 20237 holders, $177m37 holders, $18.9bn
Q4 20238 holders, $181m31 holders, $19.0bn
Q1 20245 holders, $124m32 holders, $19.7bn
Q2 20244 holders, $84m35 holders, $20.4bn
Q3 20244 holders, $94m28 holders, $22.3bn
Q4 20244 holders, $294m37 holders, $20.4bn
Q1 20255 holders, $454m32 holders, $20.5bn
Q2 20254 holders, $516m31 holders, $18.4bn
Q3 20255 holders, $527m32 holders, $23.7bn
Q4 20254 holders, $373m29 holders, $27.8bn
Q1 20263 holders, $136m34 holders, $35.6bn
Q2 20264 holders, $136m33 holders, $39.1bn
PRGO

Perrigo Co PLC

Holders
4
Reported value
$294m
Buyers
3
Sellers
2

Breadth +1 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
JNJ

Johnson & Johnson

Holders
37
Reported value
$20.4bn
Buyers
23
Sellers
12

Breadth +11 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2024

Among the 38 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only PRGO (1)

First Eagle Investment Management LLC

Only JNJ (34)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), Freestone Grove Partners LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Point72 Asset Management LP, Quantbot Technologies LP, and 9 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →